These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 17263798)

  • 1. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
    Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
    Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
    Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
    Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
    Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
    Tzung TY; Chen CY; Yang CY; Lo PY; Chen YH
    Acta Derm Venereol; 2008; 88(3):279-80. PubMed ID: 18480933
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
    Scarpa C
    Acta Derm Venereol Suppl (Stockh); 1994; 186():47. PubMed ID: 8073835
    [No Abstract]   [Full Text] [Related]  

  • 8. Once daily vs. twice daily applications of topical treatments in psoriasis.
    van de Kerkhof PC
    Br J Dermatol; 2005 Dec; 153(6):1245. PubMed ID: 16307677
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R; Gramiccia T; Frascione P; Chimenti S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriene 0.005% and betamethasone dipropionate 0.064% combination topical suspension (Taclonex Scalp).
    Scheinfeld NS
    Skinmed; 2011; 9(3):179-80. PubMed ID: 21675498
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
    Guenther LC
    Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A betamethasone-calcipotriene combination for psoriasis.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):55-6. PubMed ID: 16841023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
    Henry F; Flagothier C; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2006 Mar; 61(3):139-41. PubMed ID: 16680996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
    Downs AM
    Acta Derm Venereol; 2006; 86(1):57-8. PubMed ID: 16585991
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA; Piggott CD; Eichenfield LF
    Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
    Queille-Roussel C; Hoffmann V; Enevold A; Ganslandt C
    J Dermatolog Treat; 2013 Aug; 24(4):250-4. PubMed ID: 22103604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: a comparative study.
    Erceg A; Bovenschen HJ; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2006 Jul; 155(1):110-4. PubMed ID: 16792761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
    Cassano N; Vena GA
    Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.